ArticleDiabetic medicine : a journal of the British Diabetic Association2026
What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease?
Article in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Response to letter: 'Towards equitable implementation of AI-assisted screening for diabetic retinopathy: Perspectives on digital literacy, trust and system readiness in developing countries'.Diabetic medicine : a journal of the British Diabetic Association · 2026Article
- Towards equitable implementation of AI-assisted screening for diabetic retinopathy: Perspectives on digital literacy, trust and system readiness in developing countries.Diabetic medicine : a journal of the British Diabetic Association · 2026Article
- Cohort Profile: The North East London Diabetes Study (NELDS).International journal of epidemiology · 2026Article
- What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease?Diabetic medicine : a journal of the British Diabetic Association · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
aimsTo explore attitudes of people living with diabetes (PLD) and healthcare professionals (HCP) towards the use of automated retinal image analysis systems using artificial intelligence (AI) in NHS Diabetic Eye Screening Programmes (DESP) and how these perceptions vary by sociodemographic subgroups.
methodsTwo anonymous online surveys (28 questions for PLD and 21 for HCP) were developed to assess attitudes towards AI. Data were collected from four English DESPs, diabetes charities and patient groups between September and December 2023. Likert-scale responses were analysed using regression to examine subgroup differences.
resultsA total of 1577 PLD and 262 HCP participated. Fifty-eight per cent of PLD believed AI would perform equally well in all subgroups, compared with 32% of HCP. Seventy-one per cent of HCP disagreed that AI could replace human grading, and 81% of PLD felt humans should remain responsible for screening outcomes. Both groups supported AI's efficiency but had concerns about data security, trust, job security and who would be responsible for AI errors. Linear regression of Likert scores showed women were less accepting of AI; PLD of Black and Asian ethnicities were more cautious of data security and impact on screening experience. HCP of Asian ethnicity generally held more negative views across themes. Those using more online applications had more positive views towards AI.
conclusionsWhile both PLD and HCP recognise AI's potential benefits, concerns regarding security, job impact and errors highlight the need for targeted outreach based on sociodemographic factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.